Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival
In conclusion, PLGA-FK506-NPs are a promising formulation for spleen and lymph node delivery and have potential use in the treatment of cardiac allograft acute rejection.Graphical abstract
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Bone Graft | Cardiology | Drugs & Pharmacology | Heart | Heart Transplant | Nanotechnology | PET Scan | Study | Transplants